These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 27076760)
21. Proof of Therapeutic Efficacy of a Schulz J; Rohracker M; Stiebler M; Goldschmidt J; Stöber F; Noriega M; Pethe A; Lukas M; Osterkamp F; Reineke U; Höhne A; Smerling C; Amthauer H J Nucl Med; 2017 Jun; 58(6):936-941. PubMed ID: 28254866 [TBL] [Abstract][Full Text] [Related]
22. 111In-cetuximab as a diagnostic agent by accessible epidermal growth factor (EGF) receptor targeting in human metastatic colorectal carcinoma. Shih YH; Peng CL; Lee SY; Chiang PF; Yao CJ; Lin WJ; Luo TY; Shieh MJ Oncotarget; 2015 Jun; 6(18):16601-10. PubMed ID: 26062654 [TBL] [Abstract][Full Text] [Related]
23. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice. Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534 [TBL] [Abstract][Full Text] [Related]
24. 99mTc-Hydrazinonicotinamide epidermal growth factor-polyethylene glycol-quantum dot imaging allows quantification of breast cancer epidermal growth factor receptor expression and monitors receptor downregulation in response to cetuximab therapy. Jung KH; Choe YS; Paik JY; Lee KH J Nucl Med; 2011 Sep; 52(9):1457-64. PubMed ID: 21849406 [TBL] [Abstract][Full Text] [Related]
25. Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways. Greening DW; Lee ST; Ji H; Simpson RJ; Rigopoulos A; Murone C; Fang C; Gong S; O'Keefe G; Scott AM Oncotarget; 2015 Nov; 6(35):38166-80. PubMed ID: 26517691 [TBL] [Abstract][Full Text] [Related]
26. Biodistribution and pharmacokinetics of 188Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice. Tsai CC; Chang CH; Chen LC; Chang YJ; Lan KL; Wu YH; Hsu CW; Liu IH; Ho CL; Lee WC; Ni HC; Chang TJ; Ting G; Lee TW Int J Nanomedicine; 2011; 6():2607-19. PubMed ID: 22114492 [TBL] [Abstract][Full Text] [Related]
27. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates. Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962 [TBL] [Abstract][Full Text] [Related]
28. Maintenance Treatment with Cetuximab and BAY86-9766 Increases Antitumor Efficacy of Irinotecan plus Cetuximab in Human Colorectal Cancer Xenograft Models. Troiani T; Napolitano S; Martini G; Martinelli E; Cardone C; Normanno N; Vitagliano D; Morgillo F; Fenizia F; Lambiase M; Formisano L; Bianco R; Ciardiello D; Ciardiello F Clin Cancer Res; 2015 Sep; 21(18):4153-64. PubMed ID: 26019172 [TBL] [Abstract][Full Text] [Related]
29. Downregulation of EGFR by a novel multivalent nanobody-liposome platform. Oliveira S; Schiffelers RM; van der Veeken J; van der Meel R; Vongpromek R; van Bergen En Henegouwen PM; Storm G; Roovers RC J Control Release; 2010 Jul; 145(2):165-75. PubMed ID: 20362020 [TBL] [Abstract][Full Text] [Related]
30. MicroSPECT/CT imaging and pharmacokinetics of 188Re-(DXR)-liposome in human colorectal adenocarcinoma-bearing mice. Chen MH; Chang CH; Chang YJ; Chen LC; Yu CY; Wu YH; Lee WC; Yeh CH; Lin FH; Lee TW; Yang CS; Ting G Anticancer Res; 2010 Jan; 30(1):65-72. PubMed ID: 20150618 [TBL] [Abstract][Full Text] [Related]
31. EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model. Zalba S; Contreras AM; Merino M; Navarro I; de Ilarduya CT; Trocóniz IF; Koning G; Garrido MJ Nanomedicine (Lond); 2016; 11(5):465-77. PubMed ID: 26892017 [TBL] [Abstract][Full Text] [Related]
32. Combination therapy with zoledronic acid and cetuximab effectively suppresses growth of colorectal cancer cells regardless of KRAS status. Kato J; Futamura M; Kanematsu M; Gaowa S; Mori R; Tanahashi T; Matsuhashi N; Yoshida K Int J Cancer; 2016 Mar; 138(6):1516-27. PubMed ID: 26437179 [TBL] [Abstract][Full Text] [Related]
33. Comparative therapeutic efficacy of rhenium-188 radiolabeled-liposome and 5-fluorouracil in LS-174T human colon carcinoma solid tumor xenografts. Hsu CW; Chang YJ; Chang CH; Chen LC; Lan KL; Ting G; Lee TW Cancer Biother Radiopharm; 2012 Oct; 27(8):481-9. PubMed ID: 23067100 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of EGFR-targeted radioimmuno-gold-nanoparticles as a theranostic agent in a tumor animal model. Kao HW; Lin YY; Chen CC; Chi KH; Tien DC; Hsia CC; Lin MH; Wang HE Bioorg Med Chem Lett; 2013 Jun; 23(11):3180-5. PubMed ID: 23628334 [TBL] [Abstract][Full Text] [Related]
35. Affibody‑mediated imaging of EGFR expression in prostate cancer using radiocobalt‑labeled DOTA‑ZEGFR:2377. Mitran B; Andersson KG; Lindström E; Garousi J; Rosestedt M; Tolmachev V; Ståhl S; Orlova A; Löfblom J Oncol Rep; 2019 Jan; 41(1):534-542. PubMed ID: 30320363 [TBL] [Abstract][Full Text] [Related]
36. Generation and characterization of a target-selectively activated antibody against epidermal growth factor receptor with enhanced anti-tumor potency. Yang Y; Guo Q; Xia M; Li Y; Peng X; Liu T; Tong X; Xu J; Guo H; Qian W; Hou S; Dai J; Wang H; Liu R; Guo Y MAbs; 2015; 7(2):440-50. PubMed ID: 25679409 [TBL] [Abstract][Full Text] [Related]
37. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice. Pfost B; Seidl C; Autenrieth M; Saur D; Bruchertseifer F; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R J Nucl Med; 2009 Oct; 50(10):1700-8. PubMed ID: 19793735 [TBL] [Abstract][Full Text] [Related]
38. EGFR-targeted micelles containing near-infrared dye for enhanced photothermal therapy in colorectal cancer. Shih YH; Luo TY; Chiang PF; Yao CJ; Lin WJ; Peng CL; Shieh MJ J Control Release; 2017 Jul; 258():196-207. PubMed ID: 28445743 [TBL] [Abstract][Full Text] [Related]
39. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature. Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947 [TBL] [Abstract][Full Text] [Related]
40. In vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor. Krüwel T; Nevoltris D; Bode J; Dullin C; Baty D; Chames P; Alves F Sci Rep; 2016 Feb; 6():21834. PubMed ID: 26912069 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]